You searched for Antibody candidate - Page 24 of 69

News and Trends 5 Oct 2022

FDA fast tracks Immutep non-small cell lung cancer candidate

…first line non-small cell lung cancer (NSCLC). Efti is the company’s first-in-class soluble LAG-3 clinical stage candidate, which activates antigen presenting cells (APC) to engage both the innate and adaptive…

October 5, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 14 May 2024

Six biotechs in Belgium making leaps in the clinic

…antibody treatments for fibrosis using technology licensed from the Dutch biotech company ArgenX. Fibrosis is a condition that can damage a number of organs, including the lungs, liver, kidneys, and…

May 14, 2024 - 8 minutesmins - By Roohi Mariam Peter

Opinion 29 Nov 2023

Redefining drug development: the trailblazing evolution of the pharmaceutical industry

…after drug candidates are rigorously optimized at the preclinical stage. However, nine out of ten drug candidates would fail during phase 1, 2, 3 clinical trials and drug approval. It…

November 29, 2023 - 9 minutesmins - By External Contributor

News and Trends 20 Oct 2022

Alvotech and JAMP Pharma add two biosimilar candidates for Canadian market

Alvotech and the JAMP Pharma Group have expanded their exclusive partnership to commercialize biosimilars developed and manufactured by Alvotech. The companies have added two biosimilar candidates from Alvotech’s pipeline: AVT16,…

October 20, 2022 - 2 minutesmins - By Jim Cornall

The crucial role of rapid toxicology material delivery

Accelerating the path to clinical filing applications with rapid toxicology material delivery

…toxicology material delivery can be an effective way to reduce a drug candidate’s time to enter the clinic. Pre-clinical toxicology studies aim to provide safety data on a drug candidate,…

September 10, 2024 - 8 minutesmins - By Alexander Burik

Ryvu Therapeutics bags €22M from EIB to work on new cancer treatments

News and Trends 1 Aug 2022

Ipsen and Marengo Therapeutics partner to push immuno-oncology candidates into the clinic

Ipsen and Marengo Therapeutics, Inc. have announced a strategic partnership to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic. Ipsen also announced it is exercising its option…

August 1, 2022 - 4 minutesmins - By Jim Cornall

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

…drug, 1104. The candidate binds to monocytes – which mature into dendritic cells – and modifies the regulatory signal that causes them to activate regulatory dendritic cells, regulatory T cells…

June 27, 2023 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 23 Oct 2017

FDA Grants Belgian Crohn’s Disease Candidate Orphan Designation

TiGenix’s candidate for a nasty Crohn’s disease complication received orphan drug designation after agreeing on a global Phase III trial. TiGenix exploits the anti-inflammatory properties of donor-derived stem cells to…

October 23, 2017 - 2 minutesmins - By Alex Dale

News and Trends 16 Aug 2022

Remedium raises more funds for osteoarthritis gene therapy candidate

…candidate is the only single injection gene therapy based on the clinically proven anabolic mechanism of FGF18, which has demonstrated the ability to reverse cartilage loss in a placebo controlled,…

August 16, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 20 Jun 2023

NodThera announces positive inflammatory disease data

NodThera has announced positive data from first-in-human studies of its lead therapeutic candidates, NT-0249 and NT-0796. In the studies, both candidates were shown to clearly inhibit the NLRP3 inflammasome, a…

June 20, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 18 Jul 2022

Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease

…targeting food allergies and inflammatory bowel disease (IBD). The collaboration aims to develop and commercialize Enterome’s lead EndoMimics pipeline candidate EB1010. EB1010 is a local inducer of IL-10 designed to…

July 18, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 22 Feb 2024

10 gene therapy companies you should know about

…in vivo approaches to develop their candidates. Its lead candidate is an ex vivo therapy called reni-cell, which is intended to treat sickle cell disease and beta-thalassemia. Reni-cel is currently…

February 22, 2024 - 13 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

FDA fast tracks Immutep non-small cell lung cancer candidate

Six biotechs in Belgium making leaps in the clinic

Redefining drug development: the trailblazing evolution of the pharmaceutical industry

Alvotech and JAMP Pharma add two biosimilar candidates for Canadian market

Accelerating the path to clinical filing applications with rapid toxicology material delivery

Ipsen and Marengo Therapeutics partner to push immuno-oncology candidates into the clinic

The promise of immunotherapy for autoimmune diseases

FDA Grants Belgian Crohn’s Disease Candidate Orphan Designation

Remedium raises more funds for osteoarthritis gene therapy candidate

NodThera announces positive inflammatory disease data

Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease

10 gene therapy companies you should know about

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!